Attached files

file filename
EX-32.1 - Microbot Medical Inc.ex32-1.htm
EX-31.2 - Microbot Medical Inc.ex31-2.htm
EX-31.1 - Microbot Medical Inc.ex31-1.htm
10-Q - Microbot Medical Inc.form10-q.htm

 

Exhibit 32.2

 

Certification of Principal Financial Officer

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

 

I, David Ben Naim, Chief Financial Officer of Microbot Medical Inc., hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge, the quarterly report on Form 10-Q for the period ending March 31, 2018 of Microbot Medical Inc. (the “Form 10-Q”) fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Microbot Medical Inc.

 

Dated: May 15, 2018 /s/ David Ben Naim
  David Ben Naim
  Chief Financial Officer
  (Principal Financial Officer)